Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Esketamine for the treatment of depression

Esketamine for the treatment of depression

US Patent 11707440 · Granted Jul 25, 2023

Estimated economic value: $177,238,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the treatment of depression2025
Compositions comprising aticaprant2025
Methods of treating depression using orexin-2 receptor antagonists2025
Forms of aticaprant2024
Compositions and methods for the treatment of depression2024
Compositions and methods for the treatment of depression2024
Forms of aticaprant2024
Compositions and methods for the treatment of depression2024
Esketamine for the treatment of depression2024
Esketamine for the treatment of depression2024
Methods for the treatment of depression2022
Methods for the treatment of depression2022